1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 618 F.Supp.3d
  5. 618 F.Supp.3d 1 (2022)
 

IN RE NEW ENGLAND COMPOUNDING PHARMACY, INC.

MDL NO. 13-02419-RWZ No. 1:13-cv-10430.

618 F.Supp.3d 1 (2022)

IN RE: NEW ENGLAND COMPOUNDING PHARMACY, INC. PRODUCTS LIABILITY LITIGATION. This Document Relates to: Mattila v. New England Compounding Pharmacy, Inc.

United States District Court, D. Massachusetts.

Signed August 2, 2022.

ORDER

In November of 2012, Milda Mattila filed a product liability action against New England Compounding Pharmacy ("NECC") related to a fungal tainted steroid injection she received in August of 2012. In 2013, her case became part of this multi-district litigation, which in 2015 was resolved by a global settlement...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases